HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo.

Abstract
Pentaerythritol tetranitrate (PETN) treatment reduces progression of atherosclerosis and endothelial dysfunction and decreases oxidation of low-density lipoprotein (LDL) in rabbits. These effects are associated with decreased vascular superoxide production, but the underlying molecular mechanisms remain unknown. Previous studies demonstrated that endogenous nitric oxide could regulate the expression of extracellular superoxide dismutase (ecSOD) in conductance vessels in vivo. We investigated the effect of PETN and overexpression of endothelial nitric oxide synthase (eNOS(++)) on the expression and activity of ecSOD. C57BL/6 mice were randomized to receive placebo or increasing doses of PETN for 4 weeks and eNOS(++) mice with a several fold higher endothelial-specific eNOS expression were generated. The expression of ecSOD was determined in the lung and aortic tissue by real-time PCR and Western blot. The ecSOD activity was measured using inhibition of cytochrome C reduction. There was no effect of PETN treatment or eNOS overexpression on ecSOD mRNA in the lung tissue, whereas ecSOD protein expression increased from 2.5-fold to 3.6-fold (P < 0.05) by 6 mg PETN/kg body weight (BW)/day and 60 mg PETN/kg BW/day, respectively. A similar increase was found in aortic homogenates. eNOS(++) lung cytosols showed an increase of ecSOD protein level of 142 +/- 10.5% as compared with transgene-negative littermates (P < 0.05), which was abolished by N(omega)-nitro-L-arginine treatment. In each animal group, the increase of ecSOD expression was paralleled by an increase of ecSOD activity. Increased expression and activity of microvascular ecSOD are likely induced by increased bioavailability of vascular nitric oxide. Up-regulation of vascular ecSOD may contribute to the reported antioxidative and anti-atherosclerotic effects of PETN.
AuthorsMarc Oppermann, Vera Balz, Volker Adams, Vu Thao-Vi Dao, Murat Bas, Tatsiana Suvorava, Georg Kojda
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 13 Issue 7 Pg. 1271-8 (Jul 2009) ISSN: 1582-4934 [Electronic] England
PMID19320775 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Pentaerythritol Tetranitrate
  • Nitric Oxide Synthase Type III
  • Superoxide Dismutase
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Blood Vessels (drug effects, enzymology)
  • Enzyme Induction (drug effects)
  • Extracellular Space (drug effects, enzymology)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide Synthase Type III (metabolism)
  • Pentaerythritol Tetranitrate (pharmacology)
  • RNA, Messenger (genetics, metabolism)
  • Superoxide Dismutase (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: